Oral Oxandrolone Bioavailability: What Reaching Systemic Circulation Actually Means
Pro-Anavar is defined by its route-of-administration pharmacology: an orally ingested Oxandrolone tablet that achieves unusually high systemic exposure for a compound travelling through the hepatic portal system before entering general circulation. Most oral anabolic steroids suffer significant first-pass attrition — the liver metabolises a large fraction of the absorbed dose before it can act on peripheral androgen receptors. Oxandrolone resists this attrition because the 17α-methyl group structurally impedes hepatic oxidation, a mechanism confirmed in human pharmacokinetic studies and quantified in peer-reviewed literature at an oral bioavailability figure approaching 97% of the absorbed dose.
Injectable vs. Oral Routes: Why the Comparison Matters
Compared to injectable anabolic compounds, oral Oxandrolone bypasses the need for intramuscular or subcutaneous injection, yet it does not meaningfully sacrifice systemic availability in doing so. Injectable steroids enter the bloodstream directly, avoiding first-pass metabolism entirely — which is why many injectables are active without alkylation. Oxandrolone achieves comparable systemic delivery via the oral route specifically because the 17α-methyl modification replicates this metabolic shielding chemically. Published data place injectable testosterone bioavailability at effectively 100% (intramuscular depot absorption); oral Oxandrolone's ~97% figure represents the narrowest gap between an oral and an injectable steroid recorded in clinical pharmacology for this compound class. Pro-Anavar therefore delivers oral convenience without the bioavailability penalty typically associated with swallowing an anabolic agent.
Pro-Anavar at 50 mg/tab: Concentration, Dosing Precision and Pharma Grade Verification
At 50 mg per tablet, Pro-Anavar carries the highest per-unit Oxandrolone concentration in its product group — a formulation choice that reduces daily tablet count while maintaining dose precision. Beligas Pharmaceuticals confirms active content through HPLC (High-Performance Liquid Chromatography) analysis: declared potency is a chromatographically verified value, not a nominal label estimate. LAL (Limulus Amebocyte Lysate) endotoxin testing is applied to excipient raw materials, ensuring that tablet-binding agents carry no pyrogenic contamination risk. Three measurable quality assurances underpin each batch: HPLC quantification confirms Oxandrolone content per tablet, LAL screening clears excipient inputs, and GMP-compliant cleanroom manufacture governs the entire production environment.